234
Views
12
CrossRef citations to date
0
Altmetric
Theme: Brain/Neurologic - Review

Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review

, , &
Pages 655-667 | Published online: 10 Jan 2014

References

  • Leach L, Kaplan E, Rewilak D, Richards B, Proulx GP. Kaplan–Baycrest Neurocognitive Assessment Test Manual. The Psychological Corporation, San Antonio, TX, USA (2000).
  • Delis D, Kaplan E, Kramer J. Dellis–Kaplan Executive Function System Examiner’s and Technical Manuals. The Psychological Corporation, San Antonio, TX, USA (2001).
  • Mitrushina MN, Boone KB, D’Elia LF. Handbook of Normative Data for Neuropsychological Assessment. Oxford University Press, NY, USA (1999).
  • Woods SP, Delis DC, Scott JC, Kramer JH, Holdnack JA. The California Verbal Learning Test – second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol.21(5), 413–420 (2006).
  • Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test-Second Edition. Adult Version. The Psychological Corporation, San Antonio, TX, USA (2000).
  • Bartels C, Wegrzyn M, Wiedl A, Ackermann V, Ehrenreich H. Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci.16(11), 118 (2010).
  • Falleti MG, Maruff P, Collie A, Darby DG, McStephen M. Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%. J. Sleep. Res.12(4), 265–274 (2003).
  • Basso MR, Bornstein RA, Lang JM. Practice effects on commonly used measures of executive function across twelve months. Clin. Neuropsychol.13(3), 283–292 (1999).
  • Salthouse TA. Implications of within-person variability in cognitive and neuropsychological functioning for the interpretation of change. Neuropsychology21(4), 401–411 (2007).
  • Maruff P, Snyder PJ, Pietrzak RH, Piskulic D, Olver J, Norman T. Practice effects associated with repeated administrations of cognitive tests diminish sensitivity to cognitive enhancement in chronic schizophrenia. Presented at: New Clinical Drug Evaluation Unit Annual Meeting. Phoenix, AZ, USA, 27–30 May 2008.
  • Troster AI, Woods SP, Morgan EE. Assessing cognitive change in Parkinson’s disease: development of practice effect-corrected reliable change indices. Arch. Clin. Neuropsychol.22(6), 711–718 (2007).
  • Collie A, Darby DG, Falleti MG, Silbert BS, Maruff P. Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann. Thorac. Surg.73(6), 2005–2011 (2002).
  • Lemay S, Bedard MA, Rouleau I, Tremblay PL. Practice effect and test-retest reliability of attentional and executive tests in middle-aged to elderly subjects. Clin. Neuropsychol.18(2), 284–302 (2004).
  • Lowe C, Rabbitt P. Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues. Cambridge Neuropsychological Test Automated Battery. International Study of Post-Operative Cognitive Dysfunction. Neuropsychologia36(9), 915–923 (1998).
  • Kaminski TW, Groff RM, Glutting JJ. Examining the stability of Automated Neuropsychological Assessment Metric (ANAM) baseline test scores. J. Clin. Exp. Neuropsychol.31(6), 689–697 (2009).
  • Vardy J, Wong K, Yi QL et al. Assessing cognitive function in cancer patients. Support. Care Cancer14(11), 1111–1118 (2006).
  • Benedict RH. Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis. J. Int. Neuropsychol. Soc.11(6), 727–736 (2005).
  • Benedict RH, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J. Clin. Exp. Neuropsychol.20(3), 339–352 (1998).
  • Collie A, Maruff P, Darby DG, McStephen M. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J. Int. Neuropsychol. Soc.9(3), 419–428 (2003).
  • Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12(3), 189–198 (1975).
  • Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental Status Exam. Neurology38, 1565–1568 (1988).
  • Hoops S, Nazem S, Siderowf AD et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology73(21), 1738–1745 (2009).
  • Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J. Clin. Oncol.21(19), 3557–3558 (2003).
  • Hensel A, Angermeyer MC, Riedel-Heller SG. Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination. J. Neurol. Neurosurg. Psychiatry78(12), 1298–1303 (2007).
  • Reitan RM, Hom J, Wolfson D. Verbal processing by the brain. J. Clin. Exp. Neuropsychol.10(4), 400–408 (1988).
  • Spreen O, Strauss EA. Compendium of Neuropsychological Tests (2nd Edition). Oxford University Press, NY, USA (1998).
  • Anderson RM. Practitioner’s Guide to Clinical Neuropsychology. Plenum Press, NY, USA (1994).
  • Heilbronner RL, Henry GK, Buck P, Adams RL, Fogle T. Lateralized brain damage and performance on trail making A and B, digit span forward and backward, and TPT memory and location. Arch. Clin. Neuropsychol.6(4), 251–258 (1991).
  • Maruff P, Thomas E, Cysique L et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch. Clin. Neuropsychol.24(2), 165–178 (2009).
  • Wechsler D. WAIS-III-WMS-III Technical Manual. The Psychological Corporation, San Antonio, TX, USA (1997).
  • Bagiella E, Novack TA, Ansel B et al. Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network. J. Head Trauma Rehabil.25(5), 375–382 (2010).
  • Buck KK, Atkinson TM, Ryan JP. Evidence of practice effects in variants of the trail making test during serial assessment. J. Clin. Exp. Neuropsychol.30(3), 312–318 (2008).
  • Benton AL, Hamsher KS. Multilingual Aphasia Examination Manual (Rev. Ed.). University of Iowa, Iowa City, IA, USA (1976).
  • Marek T, Fafrowicz M, Golonka K et al. Diurnal patterns of activity of the orienting and executive attention neuronal networks in subjects performing a Stroop-like task: a functional magnetic resonance imaging study. Chronobiol. Int.27(5), 945–958 (2010).
  • Heflin LH, Laluz V, Jang J, Ketelle R, Miller BL, Kramer JH. Let’s inhibit our excitement: the relationships between Stroop, behavioral disinhibition, and the frontal lobes. Neuropsychology25(5), 655–665 (2011).
  • Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. The Psychological Corporation, San Antonio, TX, USA (1987).
  • Brandt J, Benedict RHB. Hopkins Verbal Learning Test–Revised, Professional Manual. Psychological Assessment Resources, Inc., Lutz, FL, USA (2001).
  • Delis DC, Freeland J, Kramer JH, Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J. Consult. Clin. Psychol.56(1), 123–130 (1988).
  • Delis DC, Massman PJ, Butters N, Salmon DP, Cermak LS, Kramer JH. Profiles of demented and amnestic patients on the California Verbal Learning Test: implications for the assessment of memory disorders. Psychological assessment. J. Consult. Clin. Psychol.3, 19–26 (1991).
  • Davidson PS, McFarland CP, Glisky EL. Effects of emotion on item and source memory in young and older adults. Cogn. Affect. Behav. Neurosci.6(4), 306–322 (2006).
  • Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J. Clin. Oncol.21(24), 4483–4488 (2003).
  • Harder H, Holtel H, Bromberg JE et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology62(4), 544–547 (2004).
  • Correa DD, Rocco-Donovan M, DeAngelis LM et al. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J. Neurooncol.91(3), 315–321 (2009).
  • Correa DD, Shi W, Abrey LE et al. Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol.14(1), 101–108 (2012).
  • Ferreri AJ, Reni M, Foppoli M et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised Phase 2 trial. Lancet374(9700), 1512–1520 (2009).
  • Shaw E, Arusell R, Scheithauer B et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J. Clin. Oncol.20(9), 2267–2276 (2002).
  • Brown PD, Buckner JC, O’Fallon JR et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J. Clin. Oncol.21(13), 2519–2524 (2003).
  • Laack NN, Brown PD, Ivnik RJ et al. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int. J. Radiat. Oncol. Biol. Phys.63(4), 1175–1183 (2005).
  • Vigliani MC, Sichez N, Poisson M, Delattre JY. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int. J. Radiat. Oncol. Biol. Phys.35(3), 527–533 (1996).
  • Armstrong CL, Hunter JV, Ledakis GE et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology59(1), 40–48 (2002).
  • Torres IJ, Mundt AJ, Sweeney PJ et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology60(7), 1113–1118 (2003).
  • Gondi V, Hermann BP, Mehta MP, Tome WA. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/j.ijrobp.2011.10.021 (2011) (Epub ahead of print).
  • Aoyama H, Tago M, Kato N et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int. J. Radiat. Oncol. Biol. Phys.68(5), 1388–1395 (2007).
  • Chang EL, Wefel JS, Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol.10(11), 1037–1044 (2009).
  • Roos DE, Wirth A, Burmeister BH et al. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother. Oncol.80(3), 318–322 (2006).
  • Mehta MP, Shapiro WR, Glantz MJ et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J. Clin. Oncol.20(16), 3445–3453 (2002).
  • Li J, Bentzen SM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J. Clin. Oncol.25(10), 1260–1266 (2007).
  • Welzel G, Fleckenstein K, Schaefer J et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int. J. Radiat. Oncol. Biol. Phys.72(5), 1311–1318 (2008).
  • Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol.59(1), 12–19 (1991).
  • Sun A, Bae K, Gore EM et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J. Clin. Oncol.29(3), 279–286 (2011).
  • Wolfson AH, Bae K, Komaki R et al. Primary analysis of a Phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys.81(1), 77–84 (2011).
  • Collie A, Darekar A, Weissgerber G et al. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study. Contemp. Clin. Trials28(4), 391–400 (2007).
  • Fliessbach K, Rogowski S, Hoppe C et al. Computer-based assessment of cognitive functions in brain tumor patients. J. Neurooncol.100(3), 427–437 (2010).
  • Allen BJ, Gfeller JD. The Immediate Post-Concussion Assessment and Cognitive Testing battery and traditional neuropsychological measures: a construct and concurrent validity study. Brain Inj.25(2), 179–191 (2011).
  • Edgar C, Jongen PJ, Sanders E et al. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. BMC Neurol.11, 68 (2011).
  • Collie A, Maruff P, Snyder PJ, Darekar MA, Huggins JP. Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study. Hum. Psychopharmacol.21(7), 481–488 (2006).
  • Younes M, Hill J, Quinless J et al. Internet-based cognitive testing in multiple sclerosis. Mult. Scler.13(8), 1011–1019 (2007).
  • Uysal S, Mazzeffi M, Lin HM et al. Internet-based assessment of postoperative neurocognitive function in cardiac and thoracic aortic surgery patients. J. Thorac. Cardiovasc. Surg.141(3), 777–781 (2011).
  • Darby D, Brodtmann A, Woodward M, Budge M, Maruff P. Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer’s disease. Int. Psychogeriatr. doi:10.1017/S1041610211000354 (2011) (Epub ahead of print).
  • Lewis MS, Maruff P, Silbert BS, Evered LA, Scott DA. The influence of different error estimates in the detection of postoperative cognitive dysfunction using reliable change indices with correction for practice effects. Arch. Clin. Neuropsychol.22(2), 249–257 (2007).
  • Pietrzak RH, Maruff P, Snyder PJ. Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil. J. Nutr. Health Aging13(3), 268–273 (2009).
  • Pietrzak RH, Fredrickson A, Snyder PJ, Maruff P. A comparison of statistical approaches used to evaluate change in cognitive function following pharmacologic challenge: an example with lorazepam. Hum. Psychopharmacol.25(4), 335–341 (2010).
  • Shaw EG, Berkey B, Coons SW et al. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J. Neurosurg.109(5), 835–841 (2008).
  • van den Bent MJ, Afra D, de Witte O et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet366(9490), 985–990 (2005).
  • Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin. Oncol.31(5), 702–713 (2004).
  • Gondi V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother. Oncol.97(3), 370–376 (2010).
  • Schatz P, Pardini JE, Lovell MR, Collins MW, Podell K. Sensitivity and specificity of the ImPACT Test Battery for concussion in athletes. Arch. Clin. Neuropsychol.21(1), 91–99 (2006).
  • Pietrzak RH, Snyder PJ, Jackson CE et al. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals. Hum. Psychopharmacol.24(2), 113–121 (2009).
  • Pietrzak RH, Maruff P, Snyder PJ. Convergent validity and effect of instruction modification on the groton maze learning test: a new measure of spatial working memory and error monitoring. Int. J. Neurosci.119(8), 1137–1149 (2009).
  • Fox SW, Mitchell SA, Booth-Jones M. Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting. Clin. J. Oncol. Nurs.10(2), 169–176 (2006).
  • Gehring K, Sitskoorn MM, Gundy CM et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J. Clin. Oncol.27(22), 3712–3722 (2009).
  • Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br. J. Cancer90(9), 1691–1696 (2004).
  • Klein M, Engelberts NH, van der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann. Neurol.54(4), 514–520 (2003).
  • Mathias JL, Wheaton P. Changes in attention and information-processing speed following severe traumatic brain injury: a meta-analytic review. Neuropsychology21(2), 212–223 (2007).
  • Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer95(1), 183–192 (2002).
  • Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson R Jr. Propofol and midazolam inhibit conscious memory processes very soon after encoding: an event-related potential study of familiarity and recollection in volunteers. Anesthesiology110(2), 295–312 (2009).
  • Buchsbaum BR, Padmanabhan A, Berman KF. The neural substrates of recognition memory for verbal information: spanning the divide between short- and long-term memory. J. Cogn. Neurosci.23(4), 978–991 (2011).
  • Maerlender A, Flashman L, Kessler A et al. Examination of the construct validity of ImPACT computerized test, traditional, and experimental neuropsychological measures. Clin. Neuropsychol.24(8), 1309–1325 (2010).
  • Paul LM. Two models of recognition memory: a test. J. Exp. Psychol.5(1), 45–51 (1979).
  • Fredrickson J, Maruff P, Woodward M et al. Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology34(2), 65–75 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.